Kestra Advisory Services’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Kestra Advisory Services's HALO Position: Q2 2026 in Review
Kestra Advisory Services increased its Halozyme (HALO) stake by 4% in Q2 2026, buying an estimated $26.3K and bringing the position to 10,005 shares worth $783K. The position accounts for ﹤0.01% of the portfolio, ranked #2001.
Kestra Advisory Services first reported a position in HALO in Q4 2022 and has held it in 10 quarters since. The position peaked at $932K in Q3 2024. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Kestra Advisory Services held 10,005 shares of Halozyme worth $783K as of Q2 2026.
- Kestra Advisory Services bought 385 Halozyme shares in Q2 2026, an estimated $26.3K.
- Halozyme made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2001 holding.
- Kestra Advisory Services first reported a position in Halozyme in Q4 2022 and has held it in 10 quarters since.
- Kestra Advisory Services's Halozyme position peaked at $932K in Q3 2024.
- 673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.